Michael Broom, MD
Orthopedic Surgery · Orlando, FLNPI 1750458253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Medtronic at 53.3% of the total. Reporting peaked in 2019 at $309 and has fallen 73.0% since, to $83 in 2024.
Across 36 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$399
- Amgen$246
- Medline Industries LP$79
- Pfizer$13
- Zimmer Biomet$11
What the payments were for
- Food & beverage$748100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $399 |
| Amgen | 11 | $246 |
| Medline Industries LP | 1 | $79 |
| Pfizer | 1 | $13 |
| Zimmer Biomet | 1 | $11 |
How this compares
$748 in reported general payments places this provider in the 55th percentile of 37 orthopedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 263 | $5,554 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $2,358 |
| Prednisone | 134 | $2,035 |
| Gabapentin | 149 | $1,437 |
| Tramadol Hcl | 164 | $1,324 |
| Tizanidine Hcl | 130 | $921 |
| Pregabalin | 13 | $715 |
| Methocarbamol | 87 | $691 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $579 |
| Methylprednisolone | 81 | $499 |
| Celecoxib | 24 | $492 |
| Etodolac | 20 | $464 |
| Diclofenac Potassium | 20 | $453 |
| Meloxicam | 68 | $395 |
| Morphine Sulfate | 13 | $330 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Orlando
- Gregory MartinBoynton Beach$441K
- Alejandro BadiaMiami$104K
- Ross StoneAtlantis$28K
- Eric BradleyMiami$24K
- David BuchalterDelray Beach$20K
- Richard SmithOcoee$8K
- Julio RoblaMiami$7K
- Ismael MontaneMiami$5K
- Robert McShaneTitusville$4K
- David Font-RodriguezMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.